How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
Bionic Knee Market
- By Product Type: Total Bionic Knee Implants, Partial Bionic Knee Implants, Revision Bionic Knee Implants
- By Component Material: Titanium Alloy, Cobalt-Chromium Alloy, Polyethylene, Ceramic Components
- By End User: Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers
- By Technology: Sensor-Integrated Bionic Knees, Microprocessor-Controlled Bionic Knees, Hydraulic/Pneumatic Bionic Knees
- By Application: Osteoarthritis Treatment, Rheumatoid Arthritis Treatment, Post-Traumatic Knee Reconstruction
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Total Bionic Knee Implants leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 14 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 282 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.172 →
- 12 Company Profiles 14 players: SWOT & benchmarking p.180 →
Full report · locked preview
Everything inside the Bionic Knee Market report
A complete, evidence-based study - 12 chapters and 118 sections covering market size, segmentation across 5 axes, regional analysis and 14 company profiles, forecast to 2033.
Segmentation covered
Product Type 3
Component Material 4
End User 3
Technology 3
Application 3
Companies profiled
Stryker Corporation
Zimmer Biomet Holdings Inc.
DePuy Synthes (Johnson & Johnson)
Smith & Nephew plc
Exactech Inc.
Conformis Inc.
LINK Orthopaedics
B. Braun Melsungen AG
Wright Medical Group N.V. (a part of Stryker)
MicroPort Scientific Corporation
Corin Group
OrthoSensor Inc.
+2 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
14 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Stryker Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Zimmer Biomet Holdings Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →DePuy Synthes (Johnson & Johnson)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Smith & Nephew plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Exactech Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Conformis Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →LINK Orthopaedics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →B. Braun Melsungen AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Wright Medical Group N.V. (a part of Stryker)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →MicroPort Scientific Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Corin Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →OrthoSensor Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Aesculap Implant Systems (B. Braun)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Tornier (a Wright Medical company)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →
Global · 2025–2033
$5,692M by 2033 · 8.2% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Total Bionic Knee Implants70.8
- Partial Bionic Knee Implants21.4
- Revision Bionic Knee Implants7.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,003M → $1,743M · 7.2%
Europe$698.7M → $1,310M · 8.2%
Asia Pacific$638.0M → $1,251M · 8.8%
Latin America$394.9M → $757.4M · 8.5%
Middle East and Africa$303.8M → $555.6M · 7.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →8.112026
8.132027
8.132028
8.142029
8.162030
8.172031
8.192032
8.202033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Stryker Corporation18.0
- Zimmer Biomet Holdings Inc.16.0
- DePuy Synthes (Johnson & Johnson)7.8
- Smith & Nephew plc9.3
- Exactech Inc.10.4
- Conformis Inc.10.6
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type14.7%
Component Material22.8%
End User23.8%
Technology14.6%
Application24.2%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.0
- Europe23.3
- Asia Pacific22.3
- Latin America13.5
- Middle East and Africa9.9
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Stryker Corporation | 80 | 91 | 98 | 83 | 87 | 76 | 86 |
| Zimmer Biomet Holdings Inc. | 77 | 81 | 81 | 88 | 76 | 82 | 81 |
| DePuy Synthes (Johnson & Johnson) | 76 | 81 | 67 | 79 | 74 | 73 | 75 |
| Smith & Nephew plc | 68 | 61 | 72 | 59 | 70 | 61 | 65 |
| Exactech Inc. | 65 | 73 | 76 | 72 | 54 | 65 | 68 |
| Conformis Inc. | 66 | 52 | 54 | 59 | 66 | 53 | 58 |
| LINK Orthopaedics | 59 | 62 | 66 | 64 | 46 | 53 | 58 |
| B. Braun Melsungen AG | 58 | 37 | 52 | 52 | 37 | 49 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Stryker Corporation
- Zimmer Biomet Holdings Inc.
- DePuy Synthes (Johnson & Johnson)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Stryker Corporation | ✓ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Zimmer Biomet Holdings Inc. | ✓ | ◐ | ✓ | ✓ | ◐ | ◐ |
| DePuy Synthes (Johnson & Johnson) | ◐ | ✓ | − | ✓ | ✓ | ◐ |
| Smith & Nephew plc | ✓ | ◐ | ◐ | ◐ | ✓ | ◐ |
| Exactech Inc. | ◐ | ◐ | ✓ | ◐ | ◐ | − |
| Conformis Inc. | ◐ | − | − | ◐ | − | ◐ |
| LINK Orthopaedics | ◐ | ◐ | ◐ | − | − | − |
| B. Braun Melsungen AG | ◐ | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Stryker Corporation86
2Zimmer Biomet Holdings Inc.81
3DePuy Synthes (Johnson & Johnson)75
4Exactech Inc.68
5Smith & Nephew plc65
6Conformis Inc.58
7LINK Orthopaedics58
8B. Braun Melsungen AG48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Stryker CorporationZimmer Biomet Holdings Inc.
Challenger2
Strong scale, closing on the leaders.
DePuy Synthes (Johnson & Johnson)Exactech Inc.
Contender3
Focused players with pockets of strength.
Smith & Nephew plcConformis Inc.LINK Orthopaedics
Niche1
Specialists in a single segment or region.
B. Braun Melsungen AG
Go-to-market strategy
Land Product Type in North America, then scale across Bionic Knee Market — a $617M beachhead inside a $9.87B market.
Beachhead (SOM)$617Mobtainable near-term
Serviceable (SAM)$3.95Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Total Bionic Knee Implants
Best fit — highest urgency & budget in Product Type.
Economic buyer75 fit
Partial Bionic Knee Implants
Strong fit — clear ROI and a fast path to value.
End user70 fit
Revision Bionic Knee Implants
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Component Material & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel27%
Digital / self-serve22%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Bionic Knee Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified38%
Sales qualified22%
Evaluation14%
Closed-won5%
$8.5KCAC
$36KLTV
4.2:1LTV : CAC
< 4 moCAC payback
Investment thesis
Bionic Knee Market is a resilient opportunity — $2.46B by 2033, compounding at 4.9%.
TAM · 2025$1.68Btoday
TAM · 2033$2.46Bforecast
CAGR4.9%2027–2033
Cumulative$18.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$2.46BTotal addressable market
SAM$886MServiceable available market
SOM$172MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.9% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
14+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$2.46BLarge & growingTAM by 2033 at 4.9% CAGR
$886MServiceable nowreachable with today’s model
$172MBeachhead winobtainable near-term share
14+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.92BBear3.2% CAGR
$2.46BBase4.9% CAGR
$3.15BBull6.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Component Material optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Bionic Knee Market — a $7.99B market by 2033. Plan: grow share from 7.3% to 11.2%.
Market size · 2033$7.99Btotal addressable
Market CAGR8.9%2027–2033
Target share11.2%from 7.3% today
Revenue ambition$894Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.3% | 11.2% | On track |
| Revenue | $577M | $894M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 36.5% | 41.9% | On track |
| Customer retention | 87.3% | 94.8% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Component Material capability
A defensible second engine — invest in Component Material to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Component Material
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $127M capacity & capability investment
- Greenlight bolt-on M&A in Component Material
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAhead
- Input-cost & supply riskOn track
- Regulatory / policy changeBehind
- Execution & talentAhead
Sales deck · value proposition
Win the Bionic Knee Market conversation — a $1.60B market you can size, segment and defend in minutes.
Market size · 2033$1.60Btotal opportunity
Growth8.1%CAGR to 2033
Addressable buyers1,508+accounts in scope
Typical ROI5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5×return on cost, year one
< 2 mopayback period
$86K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
14+players profiled in this market
Coverage includes
Stryker CorporationZimmer Biomet Holdings Inc.DePuy Synthes (Johnson & Johnson)Smith & Nephew plcExactech Inc.Conformis Inc.LINK OrthopaedicsB. Braun Melsungen AG+6 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Bionic Knee Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Bionic Knee Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →Bionic Leg Market
Market size, share, segmentation and regional forecast.
$3.1B market · 2025 base year
View reportBionic Pet Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportBionic Simulation Products Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportBionic Surgeon Market
Market size, share, segmentation and regional forecast.
$666M market · 2025 base year
View reportBionics Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportBionutrition Actors Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportBio-Organic Herbicide Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportbio-PE Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportBiopesticide Preparations Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportBiopesticides, Biofertilizers and Biostimulants Agricultural Biologicals Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportBiopharma Product Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportBiopharmaceutical Cmo Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report ships as a formatted PDF, a fully editable XLSX containing all underlying data tables, and a presentation-ready PPT deck - so you can re-chart, re-model, or drop any figure straight into your own deck.